MAPS

Welcome to the Brand page for “MAPS”, which is offered here for Vaccines; vaccines for the prophylaxis and treatment of infectious diseases and cancer; vaccines, immunotherapies for the treatment of infectious diseases and cancer; vaccines comprising polysaccharide antigens and protein-based antigens; vaccines, immunotherapies comprising polysaccharide antigens and protein-based antigens;research and development services in the field of vaccines; research and development services in the field of vaccines for the prophylaxis and treatment of infectious diseases and cancer; research and development services in the field of vaccines, immunotherapies for the treatment of infectious diseases and cancer; research and development in the field of vaccines comprising polysaccharide antigens and protein-based antigens; research and development in the field of vaccines, immunotherapies comprising polysaccharide antigens and protein-based antigens;.

Its status is currently believed to be active. Its class is unavailable. “MAPS” is believed to be currently owned by “Affinivax, Inc.”

Owner:
AFFINIVAX, INC.
Owner Details
Description:
Vaccines; vaccines for the prophylaxis and treatment of infectious diseases and cancer; vaccines, immunotherapies for the treatment of infectious diseases and cancer; vaccines comprising polysaccharide antigens and protein-based antigens; vaccines, immunotherapies comprising polysaccharide antigens and protein-based antigens;research and development services in the field of vaccines; research and development services in the field of vaccines for the prophylaxis and treatment of infectious diseases and cancer; research and development services in the field of vaccines, immunotherapies for the treatment of infectious diseases and cancer; research and development in the field of vaccines comprising polysaccharide antigens and protein-based antigens; research and development in the field of vaccines, immunotherapies comprising polysaccharide antigens and protein-based antigens;
Categories: VACCINES